Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Disease management in specific primary care populations

Poster Discussion
Chairs: J. Snoeck-Stroband (Leiden, Netherlands), M. L. Levy (London, United Kingdom)

Download all media

Patient-reported clinical control and peak-flow: Effects of 30 versus 6 month treatment with inhaled corticosteroids (ICS) with/without long-acting₂-agonists (LABA) in moderately severe COPD J. B. Snoeck-Stroband, T. S. Lapperre, M. M. E. Gosman, W. J. J. Assendelft, H. M. Boezen, N. H. T. ten Hacken, T. van der Molen, P. S. Hiemstra, D. S. Postma, P. J. Sterk, J. K. Sont, The Glucold Study Group (Leiden, Groningen, Amsterdam, Netherlands)
Limitation of activities in treated patients with asthma may be underestimated – Results of a cohort study Y. Martinat, G. Granet, D. Leynaud, J. Ostinelli (Lyon, Sainte Foy Les Lyon, Rueil-Malmaison, France)
Population segmentation to identify priority targets for identification and behaviour change interventions in COPD M. Kearney, J. Crighton, K. Holton, A. Moger, R. Winter, S. Hill (London, United Kingdom)
Validity and reproducibility of a physical activity questionnaire for elderly L. Siebeling, S. Wiebers, L. Beem, M. Puhan, G. ter Riet (Amsterdam, Netherlands; Baltimore, United States Of America)
Urban-rural differences in health status among patients with chronic obstructive pulmonary disease (COPD) D. Coultas, F. Su, B. Jackson, S. Suzuki, K. Lo, K. Singh, S. Bae (Tyler, Fort Worth, United States Of America)
Screening of health status in patients with COPD in primary care is essential J. Peters, L. Daudey, A. Lahaije, L. Boer, E. de Geus, J. Molema, Y. Heijdra, J. Vercoulen (Nijmegen, Netherlands)
Using community pharmacy to identify patients at risk of poor asthma control and potential contributory factors H. Reddel, K. LeMay, B. Saini, S. Bosnic-Anticevich, L. Smith, D. Burton, J. J. C. Song, M. C. Alles, K. Stewart, L. Emmerton, I. Krass, C. Armour (Sydney, Orange, Melbourne, Brisbane, Australia)
Clinical determinants for oral steroids during COPD-exacerbations in primary care P. van Velzen, R. J. B. Loijmans, M. Amelink, M. Stommel, G. ter Riet, P. J. Sterk (Amsterdam, Netherlands)
Asthma control or mental lack of control? Are they related? R. Poblet, X. Flor, L. Lamarca, J. Mendez, M. V. Feijoo, S. Alvarez (Barcelona, Spain)
Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care M. Thomas, A. Radwan, C. Stonham, S. Marshall (Aberdeen, Frimley, Stroud, Marlow, United Kingdom)
17% of patients who call an ambulance for an exacerbation of COPD could be treated at home A. Moore, J. Martin, J. Bowen, P. Katterhorn, A. Davison (Southend on Sea, Cambourne, United Kingdom)
Prescribing patterns for allergic rhinitis in general practice setting: Adherence to ARIA guidelines M. Simoni, S. Maio, S. Baldacci, A. Angino, P. Silvi, M. Borbotti, F. Martini, F. Di Pede, G. Viegi (Pisa, Palermo, Italy)
General practitioners‘ views about managing depression in patients with chronic obstructive pulmonary disease A. Yohannes (Manchester, United Kingdom)
Use of GOLD staging as a guide for treating COPD patients in primary care D. de la Rosa, A. Ocanya, P. Martínez, R. Bonich, D. Alvarez, E. Calvo, E. Albia (Barcelona, El Masnou, Vic, Spain)
Use of a pre-printed oxygen prescription section on a drug chart to improve practice of oxygen prescription and monitoring F. Ataklte, J. Wong, B. Prathibha (London, Ashford, United Kingdom)